Preliminary results of Phase II clinical trial evaluating the treatment of corneal erosion in patients with Sjogren’s syndrome
2025.05.20
The Phase II trial for corneal erosion in patients with Sjogren’s syndrome yielded statistical results demonstrating that the primary efficacy endpoint achieved statistical significance (p < 0.001).
